DK1899350T3 - Pyrazolo [3,4-D]azepinderivater som histamin-H3-antagonister - Google Patents

Pyrazolo [3,4-D]azepinderivater som histamin-H3-antagonister

Info

Publication number
DK1899350T3
DK1899350T3 DK06818218.7T DK06818218T DK1899350T3 DK 1899350 T3 DK1899350 T3 DK 1899350T3 DK 06818218 T DK06818218 T DK 06818218T DK 1899350 T3 DK1899350 T3 DK 1899350T3
Authority
DK
Denmark
Prior art keywords
antagonists
pyrazolo
histamine
azepine derivatives
derivatives
Prior art date
Application number
DK06818218.7T
Other languages
English (en)
Inventor
Mark James Bamford
David Matthew Wilson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1899350T3 publication Critical patent/DK1899350T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK06818218.7T 2005-07-06 2006-07-04 Pyrazolo [3,4-D]azepinderivater som histamin-H3-antagonister DK1899350T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0513886.2A GB0513886D0 (en) 2005-07-06 2005-07-06 Novel compounds
PCT/EP2006/006613 WO2007025596A1 (en) 2005-07-06 2006-07-04 Pyrazolo [3 , 4-d] azepine derivatives as histamine h3 antagonists

Publications (1)

Publication Number Publication Date
DK1899350T3 true DK1899350T3 (da) 2010-09-06

Family

ID=34856781

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06818218.7T DK1899350T3 (da) 2005-07-06 2006-07-04 Pyrazolo [3,4-D]azepinderivater som histamin-H3-antagonister

Country Status (27)

Country Link
US (1) US7888347B2 (da)
EP (1) EP1899350B1 (da)
JP (1) JP5145218B2 (da)
KR (1) KR20080037651A (da)
CN (1) CN101258154B (da)
AT (1) ATE467636T1 (da)
AU (1) AU2006286897A1 (da)
BR (1) BRPI0612719A2 (da)
CA (1) CA2614232A1 (da)
CR (1) CR9622A (da)
CY (1) CY1110711T1 (da)
DE (1) DE602006014273D1 (da)
DK (1) DK1899350T3 (da)
EA (1) EA013600B1 (da)
ES (1) ES2345841T3 (da)
GB (1) GB0513886D0 (da)
HR (1) HRP20100401T1 (da)
IL (1) IL188184A0 (da)
MA (1) MA29623B1 (da)
MX (1) MX2008000383A (da)
NO (1) NO20080563L (da)
PL (1) PL1899350T3 (da)
PT (1) PT1899350E (da)
SI (1) SI1899350T1 (da)
UA (1) UA93047C2 (da)
WO (1) WO2007025596A1 (da)
ZA (1) ZA200710798B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007260836B2 (en) 2006-06-23 2012-11-15 Abbvie Bahamas Ltd. Cyclopropyl amine derivatives as histamin H3 receptor modulators
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
KR20100059919A (ko) 2007-09-24 2010-06-04 코멘티스, 인코포레이티드 치료를 위한 베타-세크레타제 억제제로서 (3-히드록시-4-아미노-부탄-2일)-3-(2-티아졸-2-일-피롤리딘-1-카르보닐) 벤즈아미드 유도체 및 관련 화합물
US9186353B2 (en) * 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
WO2012037258A1 (en) 2010-09-16 2012-03-22 Abbott Laboratories Processes for preparing 1,2-substituted cyclopropyl derivatives
CN102952139B (zh) * 2011-08-30 2016-08-10 上海药明康德新药开发有限公司 反式-3a-氟吡咯烷[3,4-C]并环化合物及其制备方法
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2647377A1 (en) 2012-04-06 2013-10-09 Sanofi Use of an h3 receptor antagonist for the treatment of alzheimer's disease
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
US9910887B2 (en) * 2013-04-25 2018-03-06 Facebook, Inc. Variable search query vertical access
CN109789149A (zh) * 2016-05-25 2019-05-21 阿卡纳治疗学有限公司 用于治疗疾病的稠合双环化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1111993A4 (en) * 1998-09-09 2002-12-04 Ishihara Sangyo Kaisha CONDENSED GASOLINE DERIVATIVES TO BE USED AS HERBICIDES
EP1173438A1 (en) * 1999-04-16 2002-01-23 Novo Nordisk A/S Substituted imidazoles, their preparation and use
JP2001220390A (ja) 2000-02-09 2001-08-14 Yamanouchi Pharmaceut Co Ltd 縮合ピラゾール誘導体
JP2005529942A (ja) * 2002-06-06 2005-10-06 ノボ ノルディスク アクティーゼルスカブ 置換ピラジン類および置換アゼピン類
US6770597B2 (en) 2002-07-17 2004-08-03 Ishihara Sangyo Kaisha, Ltd. Benzohydrazide derivatives as herbicides and desiccant compositions containing them
BR0312913A (pt) 2002-07-25 2005-07-12 Pharmacia Italia Spa Ativo de biciclo-pirazóis como inibidores de cinase, processo para sua preparação e composições farmacêuticas compreendendo o mesmo
EP1539704A1 (en) 2002-08-20 2005-06-15 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
GB0224083D0 (en) 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
ATE441417T1 (de) 2002-12-20 2009-09-15 Glaxo Group Ltd Benzoädüazepinderivate für die behandlung von neurologischen krankheiten
JP5069907B2 (ja) * 2003-09-17 2012-11-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 縮合複素環式化合物
GB0329214D0 (en) 2003-12-17 2004-01-21 Glaxo Group Ltd Novel compounds
GB0405628D0 (en) 2004-03-12 2004-04-21 Glaxo Group Ltd Novel compounds
GB0408083D0 (en) 2004-04-08 2004-05-12 Glaxo Group Ltd Novel compounds
TW200611701A (en) 2004-06-18 2006-04-16 Glaxo Group Ltd Novel compounds
GB0418267D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Novel compounds
US20090306052A1 (en) 2004-12-07 2009-12-10 Glaxo Group Limited Indenyl derivatives and use thereof for the treatment of neurological disorders
US20080161289A1 (en) 2005-03-14 2008-07-03 Glaxo Group Limited Fused Thiazole Derivatives Having Affinity for the Histamine H3 Receptor

Also Published As

Publication number Publication date
WO2007025596A1 (en) 2007-03-08
EP1899350B1 (en) 2010-05-12
CN101258154B (zh) 2011-01-19
US20080176832A1 (en) 2008-07-24
HRP20100401T1 (hr) 2010-09-30
SI1899350T1 (sl) 2010-09-30
PL1899350T3 (pl) 2010-10-29
CY1110711T1 (el) 2015-06-10
MX2008000383A (es) 2008-03-07
ES2345841T3 (es) 2010-10-04
CR9622A (es) 2008-04-10
CN101258154A (zh) 2008-09-03
IL188184A0 (en) 2008-03-20
EA200800264A1 (ru) 2008-06-30
AU2006286897A1 (en) 2007-03-08
US7888347B2 (en) 2011-02-15
ZA200710798B (en) 2008-11-26
NO20080563L (no) 2008-02-01
JP2009500366A (ja) 2009-01-08
KR20080037651A (ko) 2008-04-30
DE602006014273D1 (de) 2010-06-24
PT1899350E (pt) 2010-07-21
EP1899350A1 (en) 2008-03-19
CA2614232A1 (en) 2007-03-08
BRPI0612719A2 (pt) 2010-11-30
JP5145218B2 (ja) 2013-02-13
UA93047C2 (ru) 2011-01-10
EA013600B1 (ru) 2010-06-30
ATE467636T1 (de) 2010-05-15
GB0513886D0 (en) 2005-08-10
MA29623B1 (fr) 2008-07-01

Similar Documents

Publication Publication Date Title
DK1899350T3 (da) Pyrazolo [3,4-D]azepinderivater som histamin-H3-antagonister
GB0329214D0 (en) Novel compounds
TW200621716A (en) Novel compounds
MY138478A (en) Benzazepine derivatives for the treatment of neurological disorders
TW200611701A (en) Novel compounds
CR9389A (es) Compuestos de imidazopiridazina
TW200503713A (en) Novel compounds
GEP20135780B (en) Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer agents
TW200503710A (en) Novel compounds
ATE433966T1 (de) Methylendipiperidinderivate
MX2010006748A (es) Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2.
MX2007006754A (es) Derivados de indenilo y uso de los mismos para el tratamiento de trastornos neurologicos.
NO20074977L (no) Fuserte tiazolderivater med affinitet for histamin H3 receptoren
TW200514781A (en) Novel compounds
WO2005097778A8 (en) Tetrahydrobenzazepines as histamine h3 receptor ligands
MXPA05011163A (es) Derivados de 3-benzhidriliden-8-azabiciclo[3.2.1]octano con actividad de receptores opioides.
TW200621255A (en) Novel compounds
WO2004056821A3 (en) Quinolizidine derivatives